Hematologic malignancies include a diverse group of lymphomas and leukemias that arise
in cells of the immune and lymphatic systems. In general, genetic errors of normal processes …

Hematological malignancies originate in the bone marrow, lymph nodes, and/or other
lymphoid tissue with immune function. For decades, hematological malignancies were …

Hematological malignancies comprise a collection of heterogeneous conditions, all
originating from cells of the bone marrow and the lymphatic system. There are three major …

There are data to support a role for genetic and immunerelated factors in the pathogenesis
of lymphomas and plasma cell diseases. In this paper, we review our published large …

Available evidence suggests that the incidence of leukemia and lymphoma tends to be
higher in highly developed regions of the world and among Whites in the United States …

Part of the acclaimed ACS Atlas of Clinical Oncology series, this book is designed to
summarize current knowledge on the pathology, epidemio logy, molecular biology …

Background The classification of hematological malignancies (HMs) has changed in recent
decades. For the first time, the French network of cancer registries (Francim) provides …

Objective Well-established cancer registries that routinely link to death registrations can
estimate prevalence directly by counting patients alive at a particular point in time (observed …

Roman E & Smith AG (2011) Histopathology 58, 4–14 Epidemiology of lymphomas
Epidemiological reports on lymphomas often begin, and sometimes end, by stating that little …

The classification of both Hodgkin's and non‐Hodgkin's lymphomas continues to evolve. The
current World Health Organization classification incorporates data derived from advances in …